Society for Immunotherapy of Cancer (SITC), shared a post on LinkedIn:
“The immune composition of a tumor has a major impact on immunotherapy response. Examine emerging strategies to modify tumor composition and improve therapeutic potential during,
‘Hot and Cold Tumors‘, Nov. 7 at SITC 2026.
Join Brian Brown, PhD, Antoni Ribas, MD, PhD, FAIO, and Jennifer Guerriero, PhD, as they address controversial questions surrounding the biology of hot and cold tumors. Browse the session agenda.”
Other articles about Immunotherapy on OncoDaily.